Advanced medical technology, brought to the Gulf and made to perform.
An independent GCC partner that takes advanced medical technology from registration to clinical adoption, with our own commercial and clinical teams across the region.
One accountable partner for the entire commercial journey
We run the full market-access cycle, from the regulatory file to routine clinical adoption.
Built for manufacturers who want the Gulf done properly
Most firms hand you a study and a distributor introduction, then step back. We act as your regional team, owning registration, route to market, clinical engagement, and after-sales.
See how the model worksWhat partners get
- A single regional team accountable for results
- Efficient market entry across the GCC
- Genuine clinical presence with surgeons and hospitals
- Professional, consistent product positioning
- Transparent reporting from entry through growth
Your technology, supported where it is used
Our teams work inside GCC hospitals, so your product is demonstrated and trusted by the surgeons who use it.
See the fields we coverA clear path from first review to lasting adoption
Assess and plan
We map the opportunity, the regulatory path, and clinical demand for your technology in each GCC market.
Register and prepare
We manage registration and the local groundwork so your product is compliant and ready to sell.
Launch and position
We introduce your product to the right hospitals and surgeons with professional, consistent positioning.
Grow and sustain
We build adoption, train teams, and manage after-sales so performance holds and compounds.
Technologies we represent in the region
We work with focused innovators and carry their technology into the Gulf with full clinical and commercial commitment.
CrownJun
Japan's Kono Seisakusho Group, maker of the world's smallest microsurgery needles. Precision sutures used across microsurgery, neuro, spine, orthopedics, and reconstruction.
Read more about CrownJun
BioBridge by Fibralign
A Stanford spinout. The BioBridge Collagen Matrix uses Nanoweave technology to support lymphatic repair. CE marked, FDA 510(k) cleared, and KFDA approved.
Read more about BioBridgeBring your technology to the Gulf with a partner who owns the outcome
If you are an international medical technology company evaluating the GCC, let us show you what disciplined market access looks like.
Start the conversation